Strumento inattivo

Altre lingue A.P. Pharma, Inc. OTC Bulletin Board

Azioni

APPA

US00202J2033

Prezzo di chiusura OTC Bulletin Board Altri mercati azionari
- ^USD	-

12/06	Connect Biopharma nomina un nuovo amministratore delegato e un nuovo presidente	MT
29/05	Heron Therapeutics presenta alla FDA un supplemento di approvazione preventiva per l'ago per accesso fiale di Zynrelef	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Connect Biopharma Names New Chief Executive, Chair	12/06
Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle	29/05
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")	29/05
Heron Therapeutics, Inc. Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")	29/05
Heron Therapeutics : Investor Day Presentation	15/05
Heron Therapeutics: Q1 Earnings Snapshot	07/05
Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Heron Therapeutics, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	07/05
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates	07/05
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024	24/04
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City	11/04
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference	28/03
Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024	21/03
Heron Therapeutics : Q4 2023 Earnings Call Presentation	14/03
Health Care Down on Rotation to Rate-Sensitive Sectors -- Health Care Roundup	13/03
Sector Update: Health Care Stocks Slipping Late Afternoon	13/03
Heron Therapeutics Shares Soar After Q4 Results Beat	13/03
Heron Therapeutics : Q4 2023 Earnings Call Presentation	12/03
Heron Therapeutics: Q4 Earnings Snapshot	12/03
Heron Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue A.P. Pharma, Inc. OTC Bulletin Board

Azioni

APPA

US00202J2033

Altre lingue

Filtri